Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-14

Clinical Trial Update: Pilot Study of Haloperidol to Treat Critical Illness Delirium [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating haloperidol for treating delirium in critically ill patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Delirium, Critical Illness | Phase 2 | Status: COMPLETED